title: Immunodetection of a type III sodium-dependent phosphate cotransporter in tissues and OK cells.
abstract: Polyclonal antibodies were raised in rabbits against a 14-amino acid portion of the gibbon ape leukemia virus human membrane receptor Glvr-1. This epitope also contained seven amino acids common to the receptor for the amphotropic murine retrovirus Ram-1. Antibody specificity and molecular size of Glvr-1/Ram-1-related proteins were assayed by Western blot. Using a standard Laemmli buffer system, under reducing conditions, a single band of approximately 85 kDa (designated p85) was immunodetected in membranes prepared from opossum kidney (OK) cells and in brain membranes from rat, rabbit and hamster. In mouse brain, p85 as well as a protein of 70-72 kDa were immunodetected. This protein was also present in several other mouse tissues. Limited proteolysis of p85 and the 70-72kDa-protein from mouse yielded similar peptide fragments, suggesting that both proteins are related. Fragments of the same molecular masses were also detected in OK cell membranes following proteolysis, showing that p85 in both models (mouse brain and OK cell) share a similar sequence. p85 is not N-glycosylated since an assay using endoglycosidase F/N-glycosidase F did not alter the electrophoretic mobility of p85. We also observed that regulation of phosphate transport by incubating OK cells without any phosphate or by PTH treatment occurs without any changes in the amount of p85. In conclusion, these data demonstrate for the first time a Western blot detection of a type III phosphate transporter using polyclonal antibodies. They also suggest that, conversely to type I and type II phosphate transporters which are localized in the kidney, this third type of transporter is ubiquitous and probably absorbs the readily available phosphate from interstitial fluid for normal cellular functions in many species and tissues, serving as a housekeeping Na+/Pi cotransport system. This is also the first report showing that p85 is not regulated in the same manner as type II phosphate transporters.
authors.affiliation: Laboratoire d'Oncologie Moléculaire, Université du Québec à Montréal-Hôpital Ste-Justine, Canada.
authors.forename: C J
authors.initials: CJ
authors.lastname: Boyer
authors.forename: A D
authors.initials: AD
authors.lastname: Baines
authors.forename: E
authors.initials: E
authors.lastname: Beaulieu
authors.forename: R
authors.initials: R
authors.lastname: Béliveau
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology; D015153:Blotting, Western; D002352:Carrier Proteins / Q000276:immunology / Q000378:metabolism*; D002460:Cell Line; D002918:Chymotrypsin / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D007668:Kidney / Q000166:cytology / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D009893:Opossums; D010710:Phosphates / Q000378:metabolism*; D011991:Receptors, Virus / Q000276:immunology / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*; D013045:Species Specificity
chemical_list: D000906:Antibodies; D002352:Carrier Proteins; D008565:Membrane Proteins; D010710:Phosphates; D011991:Receptors, Virus; C067981:leukemia virus receptor, gibbon ape; D012964:Sodium; D002918:Chymotrypsin